Pentobarbital will reduce the level or outcome of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers may lead into a minimize in fentanyl plasma concentrations, not enough efficacy or, perhaps, enhancement of the withdrawal syndrome inside a affected individual who's got https://roberte677ixo6.magicianwiki.com/user